We are pleased to announce an MoU with JSS Medical College and Academy of Higher Education and Research, Mysuru to work together in the areas of hemoglobinopathies and rare diseases. The aim is to work on collaborative projects to develop affordable and efficient diagnostics, therapeutics, and treatment options.
Related Posts
Developing a uniform model to track disease in the drain
TIGS was featured in a news article by the Hindu on waster... read more
Monkeypox Scare Gets Real In India: Are We Prepared? | Left, Right & Centre Interview with NDTV
All about Monkeypox, What, Why and How? Watch Dr. Rakesh Mishra, Director TIGS,... read more
Demystifying Vaccines: Evolution of mRNA-Based Platforms In Vaccines and Therapeutics
TIGS Scientists, Dr. Arati Ramesh and Dr. Rajesh Iyer, participated in the... read more
Technical Advisory Committee recommends sewage surveillance for early detection of Mpox in Karnataka
In a recently held meeting, the State Technical Advisory Committee (STAC) on... read more
Bangalore Life Science Cluster condoles death of Ratan Tata
The Bangalore Life Science Cluster (BLiSc) condoled the death of Ratan N... read more
Publication: Enrichment of phenotype among biological forms of Anopheles stephensi Liston through establishment of isofemale lines
The insectary team at TIGS along with researchers from Institute of Bioinformatics... read more
The gene whispers
TIGS got featured in a newsroom article on the Tata group website.... read more
Healthcare to agriculture: How genome revolution could be game changer
Dr. Rakesh Mishra, Director at TIGS, and Dr. Saveetha Meganathan, Research Scientist at... read more
Pandemic Far From Over, Amp Up Surveillance, Says Scientist Tracking Covid In India’s Wastewaters
Environmental surveillance of Covid-19 will be critical over the next two years.... read more
Key insights of REDRESS 2023 featured in Biospectrum India
Rare Genetic Diseases Research Summit (REDRESS) 2023, an indigenous and recurrent platform... read more

